Global InformationHelmy Eltoukhy information
Helmy Eltoukhy | |
|---|---|
 | |
| Alma mater | Stanford University BS, Electrical engineering MS, Electrical engineering PhD, Electrical engineering Stanford Genome Technology Center (Postdoc) |
| Known for | Co-Founder & CEO, Guardant Health Co-Founder & CEO, Avantome |
| Spouse | Carson Eltoukhy (? - 2020) |
| Scientific career | |
| Fields | Genomics Electrical engineering |
| Thesis | An integrated system for de novo DNA sequencing |
| Doctoral advisor | Abbas El Gamal[1][2] |
Helmy Eltoukhy is an American scientist and a businessperson who co-founded startups Avantome and Guardant Health. He is best known for his contributions to genomics, semiconductor DNA sequencing, and personalized medicine. His startups were acquired by Illumina in 2008. Avantome was founded to develop and commercialize semiconductor-based DNA sequencing, during the race for the $1,000 genome.[3] Guardant Health was founded to pioneer non-invasive liquid biopsy approaches for cancer diagnosis, monitoring, personalized medicine treatment, and research.[4][5]
- ^ "Stanford Engineering, Abbas El Gamal - Previous Students". Stanford University. 2019. Retrieved 5 Nov 2019.
- ^ Shinal, John (20 Feb 2015). "More-accurate cancer tests based on computer math". USA Today. Retrieved 5 Nov 2019.
- ^ Cite error: The named reference
zz2was invoked but never defined (see the help page). - ^ Cite error: The named reference
zz44was invoked but never defined (see the help page). - ^ Harry Glorikian; Malorye Allison Branca (20 November 2017). "Liquid Biopsies". MoneyBall Medicine: Thriving in the New Data-Driven Healthcare Market. Taylor & Francis. pp. 110–. ISBN 978-1-351-98433-1. Retrieved 19 October 2019.